Relibeta Injection

Introduction

Relibeta is a prescription medication that contains Interferon Beta-1A as its active ingredient. It is available in the form of an injection.

Uses

Relibeta is primarily prescribed for the treatment of multiple sclerosis (MS). It is used to reduce the frequency and severity of relapses in patients with relapsing forms of MS, including relapsing-remitting MS and active secondary progressive MS.

Dosage and Administration

The dosage of Relibeta may vary depending on individual patient factors and the specific condition being treated. It is typically administered as a subcutaneous injection, meaning it is injected just under the skin. The injection should be administered according to the instructions provided by your healthcare professional. Follow the recommended dosage and administration schedule to achieve the desired therapeutic effects.

Mechanism of Action

Interferon Beta-1A, the active ingredient in Relibeta, works by modulating the immune system. It helps to reduce the inflammation and autoimmune response that contribute to the development and progression of multiple sclerosis. By doing so, it can help to slow down the damage to the nerves and reduce the frequency of relapses in patients with MS.

Side Effects

Common side effects include flu-like symptoms such as fever, chills, fatigue, muscle aches, and injection site reactions such as redness, swelling, or pain at the injection site. These side effects are usually mild and tend to improve over time. However, if they persist or become bothersome, consult your healthcare professional.

In rare cases, Relibeta may also cause more serious side effects. These can include severe allergic reactions, depression or other mood changes, liver problems, and blood disorders. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

inform your healthcare professional about all medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Certain medications may interact with Relibeta and affect its effectiveness or increase the risk of side effects. Common drug interactions may include medications that suppress the immune system, such as corticosteroids or immunosuppressants. Discuss potential drug interactions with your healthcare professional before starting Relibeta.

Precautions

Before using Relibeta, inform your healthcare professional about any existing medical conditions, including allergies, liver problems, depression or other mental health conditions, and any ongoing infections. Relibeta should be used with caution in patients with certain medical conditions, and in some cases, it may be contraindicated.

Relibeta may also interact with other medications or substances, such as alcohol, which may increase the risk of side effects or affect the medication’s effectiveness. Follow your healthcare professional’s instructions and avoid any potential interactions.

Storage

Relibeta should be stored in a refrigerator at a temperature between 2°C and 8°C (36°F and 46°F). Do not freeze the medication. Keep it away from light and out of the reach of children. If the medication is not used within the recommended time frame or if it becomes discolored or contains particles, it should be discarded properly according to your local regulations.

Patient Tips

• Follow the instructions provided by your healthcare professional on how to properly administer the injection.
• If you experience flu-like symptoms, such as fever or muscle aches, after using Relibeta, inform your healthcare professional. They may recommend ways to manage these symptoms.
• Keep track of your injection sites and rotate them to minimize injection site reactions.
• If you have any concerns or questions about Relibeta, do not hesitate to contact your healthcare professional for clarification and guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Beta blockers (NHS UK) [Accessed 25 Jun. 2024] (online) Available at:
• AVONEX 30 micrograms/0.5 ml solution for injection (Health Professionals SmPC) Available at:
• Interferon beta-1a (Drugs.com) [Accessed 0 Jun. 2024] (online) Available at:
• interferon beta-1a (albumin) syringe (RX) [Accessed 16 Jun. 2024] (online) Available at:
• Interferon Beta-1a Subcutaneous Injection (MedlinePlus) [Accessed 11 Jun. 2024] (online) Available at:
• Cohen JA, Comi G, Selmaj KW, Bar-Or A, Arnold DL, Steinman L, Hartung HP, Montalban X, Kubala Havrdová E, Cree BAC, Sheffield JK, Minton N, Raghupathi K, Huang V, Kappos L; RADIANCE Trial Investigators. Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial. Lancet Neurol. 2019 Nov;18(11):1021-1033. doi: 10.1016/S1474-4422(19)30238-8. Epub 2019 Sep 3. [Accessed 27 Jun. 2024] Available at: